C URRENT OPINION Fibroblast growth factor signaling promotes physiological bone remodeling and stem cell self-renewal

Purpose of review Fibroblast growth factor (FGF) signaling activates many bone marrow cell types, including various stem cells, osteoblasts, and osteoclasts. However, the role of FGF signaling in regulation of normal and leukemic stem cells is poorly understood. This review highlights the physiological roles of FGF signaling in regulating bone marrow mesenchymal and hematopoietic stem and progenitor cells (MSPCs and HSPCs) and their dynamic microenvironment. In addition, this review summarizes the recent studies which provide an overview of FGF-activated mechanisms regulating physiological stem cell maintenance, self-renewal, and motility. Recent findings Current results indicate that partial deficiencies in FGF signaling lead to mild defects in hematopoiesis and bone remodeling. However, FGF signaling was shown to be crucial for stem cell self-renewal and for proper hematopoietic poststress recovery. FGF signaling activation was shown to be important also for rapid AMD3100 or post 5-fluorouracil-induced HSPC mobilization. In vivo, FGF-2 administration successfully expanded both MSPCs and HSPCs. FGF-induced expansion was characterized by enhanced HSPC cycling without further exhaustion of the stem cell pool. In addition, FGF signaling expands and remodels the supportive MSPC niche cells. Finally, FGF signaling is constitutively activated in many leukemias, suggesting that malignant HSPCs exploit this pathway for their constant expansion and for remodeling a malignant-supportive microenvironment. Summary The summarized studies, concerning regulation of stem cells and their microenvironment, suggest that FGF signaling manipulation can serve to improve current clinical stem cell mobilization and transplantation protocols. In addition, it may help to develop therapies specifically targeting leukemic stem cells and their supportive microenvironment.

[1]  J. Rasko,et al.  Nichotherapy for stem cells: there goes the neighborhood. , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  Xiaogang Wang,et al.  miR-214 targets ATF4 to inhibit bone formation , 2012, Nature Medicine.

[3]  L. Calvi,et al.  PTH expands short-term murine hemopoietic stem cells through T cells. , 2012, Blood.

[4]  S. Erzurum,et al.  Endothelial Apelin-FGF Link Mediated by MicroRNAs 424 and 503 is Disrupted in Pulmonary Arterial Hypertension , 2012, Nature Medicine.

[5]  R. Adams,et al.  Endothelial Blood-Bone Marrow-Barrier Dynamically Regulates Balanced Stem and Progenitor Cell Trafficking and Maintenance , 2012 .

[6]  Daniel G. Anderson,et al.  FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. , 2012, Cell reports.

[7]  Xi C. He,et al.  FGF signaling facilitates postinjury recovery of mouse hematopoietic system. , 2012, Blood.

[8]  G. Enikolopov,et al.  FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation. , 2012, Blood.

[9]  A. Papadimitropoulos,et al.  Fibroblast Growth Factor‐2 Maintains a Niche‐Dependent Population of Self‐Renewing Highly Potent Non‐adherent Mesenchymal Progenitors Through FGFR2c , 2012, Stem cells.

[10]  L. Vecchio,et al.  Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways? , 2012, Cellular signalling.

[11]  D. Gridley,et al.  Erythroid Promoter Confines FGF2 Expression to the Marrow after Hematopoietic Stem Cell Gene Therapy and Leads to Enhanced Endosteal Bone Formation , 2012, PloS one.

[12]  Lei Ding,et al.  Endothelial and perivascular cells maintain haematopoietic stem cells , 2011, Nature.

[13]  A. Iwama,et al.  Nonmyelinating Schwann Cells Maintain Hematopoietic Stem Cell Hibernation in the Bone Marrow Niche , 2011, Cell.

[14]  J. Bogousslavsky,et al.  Trafermin for stroke recovery: is it time for another randomized clinical trial? , 2011, Expert opinion on biological therapy.

[15]  D. Coutu,et al.  Roles of FGF signaling in stem cell self-renewal, senescence and aging , 2011, Aging.

[16]  Liping Xiao,et al.  The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expression. , 2011, Biochemical and biophysical research communications.

[17]  D. Coutu,et al.  Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. , 2011, Blood.

[18]  Kai-yan Liu,et al.  Stromal-derived factor-1 deficiency in the bone marrow of acute myeloid leukemia , 2011, International journal of hematology.

[19]  M. Vodyanik,et al.  Endothelial origin of mesenchymal stem cells , 2011, Cell cycle.

[20]  P. Guttorp,et al.  The replication rate of human hematopoietic stem cells in vivo. , 2011, Blood.

[21]  N. Horwood,et al.  Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. , 2011, Blood.

[22]  G. Lozano,et al.  Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. , 2010, Cell stem cell.

[23]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[24]  Ian A. White,et al.  Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. , 2010, Cell stem cell.

[25]  T. Doetschman,et al.  Endogenous FGF‐2 is critically important in PTH anabolic effects on bone , 2009, Journal of cellular physiology.

[26]  M. Ittmann,et al.  Paths of FGFR-driven tumorigenesis , 2009, Cell cycle.

[27]  Angela C. Colmone,et al.  Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells , 2008, Science.

[28]  K. Miyamoto,et al.  Foxo3a is essential for maintenance of the hematopoietic stem cell pool , 2009 .

[29]  S. Mohan,et al.  Sca-1+ Hematopoietic Cell-based Gene Therapy with a Modified FGF-2 Increased Endosteal/Trabecular Bone Formation in Mice. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  H. Nakauchi,et al.  Foxo3a is essential for maintenance of the hematopoietic stem cell pool. , 2007, Cell stem cell.

[31]  J. Nardone,et al.  Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia. , 2006, Blood.

[32]  T. Nagasawa,et al.  Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. , 2006, Immunity.

[33]  O. Kollet,et al.  Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. , 2006, Experimental hematology.

[34]  S. Rafii,et al.  Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells , 2006, Leukemia.

[35]  E. Vellenga,et al.  Fibroblast Growth Factor‐1 and ‐2 Preserve Long‐Term Repopulating Ability of Hematopoietic Stem Cells in Serum‐Free Cultures , 2006, Stem cells.

[36]  Ari Elson,et al.  Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells , 2006, Nature Medicine.

[37]  Keisuke Ito,et al.  Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells , 2006, Nature Medicine.

[38]  M. Ito,et al.  Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. , 2006, Biochemical and biophysical research communications.

[39]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[40]  S. Rafii,et al.  The bone marrow vascular niche: home of HSC differentiation and mobilization. , 2005, Physiology.

[41]  Xunbin Wei,et al.  In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.

[42]  P. Dell’Era,et al.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.

[43]  I. Kashiwakura,et al.  Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells , 2005, Leukemia & lymphoma.

[44]  E. Crivellato,et al.  Hematopoietic cancer and angiogenesis. , 2004, Stem cells and development.

[45]  D. Ribatti,et al.  Angiogenesis in acute and chronic lymphocytic leukemia. , 2004, Leukemia research.

[46]  W. Berdel,et al.  Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia. , 2003, Cancer research.

[47]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[48]  Haiyang Huang,et al.  Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.

[49]  T. Doetschman,et al.  Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone* , 2003, Journal of Biological Chemistry.

[50]  E. Vellenga,et al.  In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. , 2003, Developmental cell.

[51]  A. Bikfalvi,et al.  The role of fibroblast growth factors in vascular development. , 2002, Trends in molecular medicine.

[52]  P. Dell’Era,et al.  Fibroblast Growth Factors and Their Receptors in Hematopoiesis and Hematological Tumors , 2002 .

[53]  E. Estey,et al.  Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. , 2000, Blood.

[54]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[55]  Z. Fuks,et al.  Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. , 2000, Cancer research.

[56]  S. Tsang,et al.  Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Taichman,et al.  The Role of Osteoblasts in the Hematopoietic Microenvironment , 1998, Stem cells.

[58]  A. König,et al.  Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis , 1997, Leukemia.

[59]  E. Calleja,et al.  Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. , 1996, Blood.

[60]  J. Rossant,et al.  fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. , 1994, Genes & development.

[61]  J. Schwartz,et al.  Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. , 1994, Cancer research.

[62]  P. D’Amore.  Modes of FGF release in vivo and in vitro , 1990, Cancer and Metastasis Reviews.

[63]  P. Okunieff,et al.  Fibroblast growth factor-peptide promotes bone marrow recovery after irradiation. , 2013, Advances in experimental medicine and biology.

[64]  R. Kalluri,et al.  Contribution of bone microenvironment to leukemogenesis and leukemia progression , 2009, Leukemia.

[65]  T. J. Poole,et al.  The role of FGF and VEGF in angioblast induction and migration during vascular development , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.